Breast, OptimICE-pCR: A012103

This phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab.

Pamela Coffey Discusses Dealing with Cancer during the Holidays

Pamela Coffey is a Licensed Clinical Social Worker who works with cancer patients and their families at Hematology-Oncology Associat

Patient Newsletter 2023 December

January 2024 Advocacy Update on Seniors' Access to Critical Medications

Problem/Issue:
In September 2021, the Centers for Medicare & Medicaid Services (CMS) published a Frequently Asked Questions document (FAQ) prohibiting physicians from delivering oral cancer drugs and other medications to their patients by mail, FedEx, UPS, courier, or other means. CMS’ FAQ also prohibits a spouse, family member, or caregiver from picking up medication on a patient’s behalf.

Cancer Q&A - Kimberly Conboy and Kristen Weiler

Kimberly Conboy and Kristen Weiler discuss
cancer genetics testing

All About Cancer Genetics Testing

Lung, D926NC0001 “AVANZAR”

Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin for First-Line Treatment of Patients With Advanced NSCLC Without Actionable Genomic Alterations

Patient Newsletter 2023 November

Lung Cancer Awareness Month with Dr. Kavitha Prezzano, Radiation Oncologist at HOA

Dr. Kavitha Prezzano discusses Lung Cancer Awareness Month on our Bridge Street segment "Cancer Q&A with HOA."

Patient Newsletter 2023 October

Pages